Dopamine induces glutamate accumulation in astrocytes to disrupt neuronal function leading to pathogenesis of minimal hepatic encephalopathy

[1]  Zhaoqian Liu,et al.  Huperzine A Alleviates Oxidative Glutamate Toxicity in Hippocampal HT22 Cells via Activating BDNF/TrkB-Dependent PI3K/Akt/mTOR Signaling Pathway , 2016, Cellular and Molecular Neurobiology.

[2]  D. Grandy,et al.  "TAARgeting Addiction"--The Alamo Bears Witness to Another Revolution: An Overview of the Plenary Symposium of the 2015 Behavior, Biology and Chemistry Conference. , 2016, Drug and alcohol dependence.

[3]  A. Ghorpade,et al.  Methamphetamine and HIV-1-induced neurotoxicity: Role of trace amine associated receptor 1 cAMP signaling in astrocytes , 2014, Neuropharmacology.

[4]  J. Kiecolt-Glaser,et al.  Psychiatry and social nutritional neuroscience , 2014, World psychiatry : official journal of the World Psychiatric Association.

[5]  P. Gubellini,et al.  Progressive Parkinsonism by acute dysfunction of excitatory amino acid transporters in the rat substantia nigra , 2014, Neurobiology of Disease.

[6]  S. Ferreira,et al.  Amyloid-β oligomers induce tau-independent disruption of BDNF axonal transport via calcineurin activation in cultured hippocampal neurons , 2013, Molecular biology of the cell.

[7]  Stephen R. Morairty,et al.  A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight , 2013, Molecular Psychiatry.

[8]  Bicheng Chen,et al.  Dopamine from cirrhotic liver contributes to the impaired learning and memory ability of hippocampus in minimal hepatic encephalopathy , 2013, Hepatology International.

[9]  R. Malinow,et al.  Metabotropic NMDA receptor function is required for NMDA receptor-dependent long-term depression , 2013, Proceedings of the National Academy of Sciences.

[10]  K. Baumgärtel,et al.  Neural functions of calcineurin in synaptic plasticity and memory. , 2012, Learning & memory.

[11]  A. Romano,et al.  Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease , 2012, Neurobiology of Aging.

[12]  D. Pak,et al.  Wherefore Art Thou, Homeo(stasis)? Functional Diversity in Homeostatic Synaptic Plasticity , 2012, Neural plasticity.

[13]  H. Man,et al.  AMPA Receptor Trafficking in Homeostatic Synaptic Plasticity: Functional Molecules and Signaling Cascades , 2012, Neural plasticity.

[14]  G. Zhao,et al.  Ginsenoside Rd attenuates mitochondrial dysfunction and sequential apoptosis after transient focal ischemia , 2011, Neuroscience.

[15]  D. Sandstrom,et al.  NFAT regulates pre-synaptic development and activity-dependent plasticity in Drosophila , 2011, Molecular and Cellular Neuroscience.

[16]  Gregory M. Miller,et al.  The emerging role of trace amine‐associated receptor 1 in the functional regulation of monoamine transporters and dopaminergic activity , 2011, Journal of neurochemistry.

[17]  Y. Wang,et al.  Changes of Serum Brain-Derived Neurotrophic Factor in Children with Obstructive Sleep Apnoea–Hypopnoea Syndrome following Adenotonsillectomy , 2010, The Journal of international medical research.

[18]  K. Seyb,et al.  Identification of Translational Activators of Glial Glutamate Transporter EAAT2 through Cell-Based High-Throughput Screening , 2010, Journal of biomolecular screening.

[19]  S. Cohen-Cory,et al.  Brain‐derived neurotrophic factor and the development of structural neuronal connectivity , 2010, Developmental neurobiology.

[20]  E. S. Ruthazer,et al.  Neural Activity Regulates Synaptic Properties and Dendritic Structure In Vivo through Calcineurin/NFAT Signaling , 2009, Neuron.

[21]  Y. Chawla,et al.  Minimal hepatic encephalopathy , 2009, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[22]  R. Neubig,et al.  International Union of Pharmacology. LXXII. Recommendations for Trace Amine Receptor Nomenclature , 2009, Pharmacological Reviews.

[23]  H. Lui,et al.  Minimal hepatic encephalopathy runs a fluctuating course: results from a three-year prospective cohort follow-up study. , 2009, Singapore medical journal.

[24]  T. Macedo,et al.  Methamphetamine Changes NMDA and AMPA Glutamate Receptor Subunit Levels in the Rat Striatum and Frontal Cortex , 2008, Annals of the New York Academy of Sciences.

[25]  T. Sotnikova,et al.  Pharmacological Characterization of Membrane-Expressed Human Trace Amine-Associated Receptor 1 (TAAR1) by a Bioluminescence Resonance Energy Transfer cAMP Biosensor , 2008, Molecular Pharmacology.

[26]  G. Taglialatela,et al.  Acute inhibition of calcineurin restores associative learning and memory in Tg2576 APP transgenic mice , 2007, Neurobiology of Learning and Memory.

[27]  Ying-Chen Yang,et al.  Serum- and Glucocorticoid-Inducible Kinase 1 (SGK1) Increases Neurite Formation through Microtubule Depolymerization by SGK1 and by SGK1 Phosphorylation oftau , 2006, Molecular and Cellular Biology.

[28]  R. Miledi,et al.  Effects of cyclothiazide on GluR1/AMPA receptors. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Harper,et al.  A Calcium-Regulated MEF2 Sumoylation Switch Controls Postsynaptic Differentiation , 2006, Science.

[30]  I. Nishimoto,et al.  Implanted cannula-mediated repetitive administration of Aβ25–35 into the mouse cerebral ventricle effectively impairs spatial working memory , 2005, Behavioural Brain Research.

[31]  Wade Morishita,et al.  Distinct triggering and expression mechanisms underlie LTD of AMPA and NMDA synaptic responses , 2005, Nature Neuroscience.

[32]  E. Blalock,et al.  Calcineurin Triggers Reactive/Inflammatory Processes in Astrocytes and Is Upregulated in Aging and Alzheimer's Models , 2005, The Journal of Neuroscience.

[33]  Martin Ebeling,et al.  Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors. , 2005, Genomics.

[34]  Long Yu,et al.  Characterization of a human regulatory subunit of protein phosphatase 3 gene (PPP3RL) expressed specifically in testis , 2005, Molecular Biology Reports.

[35]  T. Iwatsubo,et al.  Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice , 2004, The European journal of neuroscience.

[36]  Maiken Nedergaard,et al.  Astrocyte-mediated activation of neuronal kainate receptors. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[37]  T. Hayase,et al.  Brain excitatory amino acid transporters (EAATs) and treatment of methamphetamine toxicity. , 2003, Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence.

[38]  E. Huang,et al.  Trk receptors: roles in neuronal signal transduction. , 2003, Annual review of biochemistry.

[39]  P. Mermelstein,et al.  Brain-Derived Neurotrophic Factor Activation of NFAT (Nuclear Factor of Activated T-Cells)-Dependent Transcription: A Role for the Transcription Factor NFATc4 in Neurotrophin-Mediated Gene Expression , 2003, The Journal of Neuroscience.

[40]  F. Miller,et al.  Endogenously Produced Neurotrophins Regulate Survival and Differentiation of Cortical Progenitors via Distinct Signaling Pathways , 2003, The Journal of Neuroscience.

[41]  M. Mattson,et al.  Nitric oxide acts in a positive feedback loop with BDNF to regulate neural progenitor cell proliferation and differentiation in the mammalian brain. , 2003, Developmental biology.

[42]  Fan Wang,et al.  Neurotrophins and Netrins Require Calcineurin/NFAT Signaling to Stimulate Outgrowth of Embryonic Axons , 2003, Cell.

[43]  S. Amara,et al.  Excitatory amino acid transporters: keeping up with glutamate , 2002, Neurochemistry International.

[44]  M. Mattson,et al.  Evidence that brain‐derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice , 2002, Journal of neurochemistry.

[45]  E. Ziff,et al.  Receptor trafficking and the plasticity of excitatory synapses , 2002, Current Opinion in Neurobiology.

[46]  G. Crabtree,et al.  NFAT Signaling Choreographing the Social Lives of Cells , 2002, Cell.

[47]  D. Grandy,et al.  Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. , 2001, Molecular pharmacology.

[48]  Beth Borowsky,et al.  Trace amines: Identification of a family of mammalian G protein-coupled receptors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Ana Gadea,et al.  Glial transporters for glutamate, glycine and GABA I. Glutamate transporters , 2001, Journal of neuroscience research.

[50]  M. Hesselink,et al.  Extracellular Concentrations of Taurine, Glutamate, and Aspartate in the Cerebral Cortex of Rats at the Asymptomatic Stage of Thioacetamide-Induced Hepatic Failure: Modulation by Ketamine Anesthesia , 2000, Neurochemical Research.

[51]  R. Swanson,et al.  Astrocyte glutamate transport: Review of properties, regulation, and physiological functions , 2000, Glia.

[52]  C. Hock,et al.  Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. , 2000, Archives of neurology.

[53]  K. Deisseroth,et al.  L-type calcium channels and GSK-3 regulate the activity of NF-ATc4 in hippocampal neurons , 1999, Nature.

[54]  J. Isaac,et al.  Lack of AMPA receptor desensitization during basal synaptic transmission in the hippocampal slice. , 1999, Journal of neurophysiology.

[55]  J C Reed,et al.  Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. , 1999, Science.

[56]  R. Faull,et al.  Brain-derived neurotrophic factor is reduced in Alzheimer's disease. , 1997, Brain research. Molecular brain research.

[57]  K. McCarthy,et al.  ASTROCYTIC NEUROTRANSMITTER RECEPTORS IN SITU AND IN VIVO , 1997, Progress in Neurobiology.

[58]  S. Tsuji,et al.  Regional specificity of alterations in NGF, BDNF and NT‐3 levels in Alzheimer's disease , 1996, Neuroreport.

[59]  C. Benoist,et al.  A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. , 1996, Human gene therapy.

[60]  I. Izquierdo,et al.  Hippocampal cGMP and cAMP are differentially involved in memory processing of inhibitory avoidance learning , 1996, Neuroreport.

[61]  Jeffrey S. Diamond,et al.  Asynchronous release of synaptic vesicles determines the time course of the AMPA receptor-mediated EPSC , 1995, Neuron.

[62]  T. Hoey,et al.  Isolation of two new members of the NF-AT gene family and functional characterization of the NF-AT proteins. , 1995, Immunity.

[63]  D. D. Fraser,et al.  Astrocytic GABA receptors , 1994, Glia.

[64]  J. Coyle,et al.  Oxidative stress, glutamate, and neurodegenerative disorders. , 1993, Science.

[65]  L. Vyklický,et al.  Hippocampal neurons exhibit cyclothiazide-sensitive rapidly desensitizing responses to kainate , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[66]  D. Choi.  Excitotoxic cell death. , 1992, Journal of neurobiology.

[67]  H. Abdul,et al.  NFATs and Alzheimer's Disease. , 2010, Molecular and cellular pharmacology.

[68]  M. Robinson,et al.  Expression patterns and regulation of glutamate transporters in the developing and adult nervous system. , 1999, Critical reviews in neurobiology.

[69]  J. Coyle,et al.  Oxidative stress in neurodegenerative diseases. , 1996, Annual review of pharmacology and toxicology.